424B5 Filing detail
$SNDL Inc (SNDL.US)$
"On January 22, 2021, we received a notice from Zenabis Investments Ltd. (“Zenabis”), a subsidiary of Zenabis Global Inc., stating its intention to repay the full principal amount and interest outstanding under the senior secured debt of Zenabis (the “Senior Loan”) owing to Sundial, of approximately $51.9 million, on February 4, 2021. There can be no assurance that Zenabis will repay the Senior Loan. Any repayment of the Senior Loan will not affect the recurring royalty payments owed by Zenabis to Sundial."
"On January 22, 2021, we received a notice from Zenabis Investments Ltd. (“Zenabis”), a subsidiary of Zenabis Global Inc., stating its intention to repay the full principal amount and interest outstanding under the senior secured debt of Zenabis (the “Senior Loan”) owing to Sundial, of approximately $51.9 million, on February 4, 2021. There can be no assurance that Zenabis will repay the Senior Loan. Any repayment of the Senior Loan will not affect the recurring royalty payments owed by Zenabis to Sundial."
Anybody's thoughts welcomed here?
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Eccentric Ass MF, Trading to try and ditch the Nine 2 Fiver!
34Followers
59Following
91Visitors
Follow
DEADSEED1111 : Holy Bat shit Robin... it might actually start budding... strong maybe....
NYourHead OP : @OfficerTruth Want to give us an analysis, Besides I'm curious your take on that quick dip in the market today, seen it impact several tickers simultaneously, started 11:04 ending 11:15. Perhaps a glitch in the Matrix?
wolfunstien NYourHead OP : That’s the government taking money for the black book ops
OFFICER TRUTH : This is not my original content or research. This is research done from the only perspective I trust in regards to $$SNDL Inc (SNDL.US)$ @NYourHead
ALL 
GOOD 
NEWS 
Clinical Trials for PathwayRX start January 2021. Four month trials are funded by $1.1B government funding and should last four months. Sundial owns 50% of PathwayRX.
SUNDIAL has an offering listed in a key New York Investment Bank. Gov. Cuomo lists recreational legalization a top priority in his early 2021 plan. SUNDIAL will have the capital to quickly move into the emerging US market.
Top Leaf brands, a premiere brand of Sundial earned #1 Brand Packaging and #2 Overall Brand by ADCANN.
Sundial owns the $58m loan that Zenabis pays to us. It carries a 14% interest rate and royalty deal. Zenabis is scrambling to refinance which will result in an early principle payment. The Royalty portion is 2-3% of Z sales and will last 96 months, even if the loan is paid early. This will go directly to Sundial Revenue.
Chokolat, SimplySolventless Concentrates, C02 Vape design, Top Leaf potency, CBD Genoming, Reduced growing cost with increased quality.
1) they issued a supplement 4245B and dumb (sorry I mean insure) investors think it is an additional offering. It is just an update, no change in the amount.
OFFICER TRUTH OFFICER TRUTH : He is one of our favorite members in our trade community :)
NYourHead OP OFFICER TRUTH : Thanks for the good news@OfficerTruth I did see their subsidiary ownership in their last financials statement.
DEADSEED1111 wolfunstien : let's go and trade in that book too...
treydongui : my first thought was buy that b**** lol. done. haha thanks for sharing man that's awesome of you
treydongui : btw, followed. thank you